2012 Clinician Scientist Panel

Dr. Laurence Klotz, Chair
Clinical Uro-oncologist
Chief, Division of Urology 
Sunnybrook Health Sciences Centre
Toronto, ON

Dr. Armen G. Aprikian, Co-chair
Clinical Uro-oncologist
Head Division of Urology 
McGill University Health Centre 
Montreal General Hospital
Montreal, QC

Dr. Jeremy Squire
Research Chair in Molecular Pathology, Pathology & Molecular Medicine
Professor Pathology & Molecular Medicine, Pathology & Molecular Medicine
Director NCIC Clinical Trials Group, Cancer Biology & Genetics 
Queen's University 
Kingston, ON

Dr. Himansu (Himu) Lukka
Professor, Department of Oncology
Division of Radiation Oncology 
McMaster University 
Hamilton, ON

Dr. Danny Vesprini, Science Officer
Department of Radiation Oncology 
Sunnybrook Hospital
Toronto, ON

Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive